Neil McFarlane
Chief Executive Officer presso ZEVRA THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Neil F.
McFarlane is currently the President, Chief Executive Officer & Director at Zevra Therapeutics, Inc. and an Independent Director at Collegium Pharmaceutical, Inc. Previously, he served as the Chief Executive Officer at Adamas Pharmaceuticals LLC from 2019 to 2021, and as the Vice President at UCB, Inc. from 2011 to 2016.
He also served as the Chief Operating Officer at Travere Therapeutics, Inc. from 2016 to 2019.
McFarlane received his undergraduate and graduate degrees from the University of Florida.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/05/2023 | 41 672 ( 0.13% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Neil McFarlane
| Società | Posizione | Inizio |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 06/04/2022 |
| ZEVRA THERAPEUTICS, INC. | Chief Executive Officer | 10/10/2023 |
Precedenti posizioni note di Neil McFarlane
| Società | Posizione | Fine |
|---|---|---|
| Adamas Pharmaceuticals, Inc. | Chief Executive Officer | 01/11/2021 |
| ADAMAS PHARMACEUTICALS, INC. | Chief Executive Officer | 01/01/2021 |
| TRAVERE THERAPEUTICS, INC. | Chief Operating Officer | 31/05/2019 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Corporate Officer/Principal | 01/01/2016 |
Formazione di Neil McFarlane
| University of Florida | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Finance |
| Adamas Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- Neil McFarlane
